Aclaris Therapeutics (ACRS) Intangibles (2017 - 2023)

Aclaris Therapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $269000.0 for Q4 2023.

• In Q4 2023, Intangibles fell 96.36% year-over-year to $269000.0; the TTM figure through Dec 2023 stood at $269000.0 (down 96.36% YoY), while the FY2023 annual figure was $269000.0, down 96.36% from the prior year.
• Intangibles was $269000.0 for Q4 2023 at Aclaris Therapeutics, down from $6.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $73.8 million in Q1 2019 to a low of $269000.0 in Q4 2023.
• Historically, Intangibles has averaged $13.1 million across 5 years, with a median of $7.1 million in 2020.
• The sharpest annual moves came in 2019 and 2023: Intangibles soared 909.37% in 2019, then plunged 96.36% in 2023.
• A 5-year view of Intangibles shows it stood at $7.4 million in 2019, then decreased by 3.48% to $7.1 million in 2020, then climbed by 3.61% to $7.4 million in 2021, then changed by 0.0% to $7.4 million in 2022, then slumped by 96.36% to $269000.0 in 2023.
• The last three Intangibles figures came in at $269000.0 (Q4 2023), $6.9 million (Q3 2023), and $6.9 million (Q2 2023), per Business Quant data.